Webinar
Resolving Inflammation: From the Science to the Protocol
Speakers
Malisa Carullo, MSc, ND
40 minutes
Sign up for Academy to watch the recording
Recordings of all live sessions are free with a Fullscript Academy account
Create free account
Have an account?
About this webinar
The resolution of inflammation is an actively regulated biochemical process, not the passive decay of an inflammatory stimulus. Failure of that process characterizes the persistent low-grade inflammation underlying cardiometabolic, musculoskeletal, and neuroinflammatory disease.
This webinar examines the enzymatic basis of lipid mediator class switching and translates it into a structured clinical approach: modulating initiation, correcting substrate and cofactor status, and supporting resolution directly. Patient selection, sequencing, and expected time courses are addressed throughout.
Key takeaways
- Understand the biochemical basis of inflammation resolution as an actively regulated program, and account for why sustained cyclooxygenase inhibition impairs it.
- Apply a three-part framework (modulating initiation, correcting omega-3 and magnesium status, and supporting resolution) to a specific patient presentation, including the formulation characteristics that determine whether a bioactive compound reaches tissue.
- Appraise the current human evidence for specialized pro-resolving mediator supplementation and communicate realistic onset expectations to patients.
